Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Bunka currently holds 273,543 shares of Lexaria Bioscience Corp. (LXRP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Bunka has been a net buyer of LXRP stock. They have purchased $2.5M and sold $0 worth of shares.
Christopher Bunka's most recent insider trade was on Mar 17, 2026, when they sold 100,000 shares at $0.00 per share.
Christopher Bunka serves as Executive at Lexaria Bioscience Corp. (LXRP). They have executed 728 insider transactions totaling $2.5M over their tenure at the company.
Christopher Bunka holds the position of Executive at Lexaria Bioscience Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Christopher Bunka has shown a buying trading pattern, with $2.5M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher Bunka was on Aug 3, 2018, when they purchased $100.8K worth of LXRP shares. This transaction involved 81,250 shares at $1.24 per share.
Christopher Bunka currently owns 273,543 shares of Lexaria Bioscience Corp. (LXRP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Bunka's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Bunka has 728 Form 4 filings on record as an insider at Lexaria Bioscience Corp..
Set alerts for Christopher Bunka and 40,000+ other insiders.